Clinical Trial: A Randomized, Double-blind, Placebo-controlled, Multicenter Phase II/III Clinical Study of Adebrelimab in Combination With SHR-8068 and Chemoradiotherapy as Perioperative Therapy for Locally Advanced Rectal Cancer

U.S., March 7 -- ClinicalTrials.gov registry received information related to the study (NCT07454720) titled 'A Randomized, Double-blind, Placebo-controlled, Multicenter Phase II/III Clinical Study of Adebrelimab in Combination With SHR-8068 and Chemoradiotherapy as Perioperative Therapy for Locally Advanced Rectal Cancer' on Feb. 25.

Brief Summary: The study is being conducted to evaluate the safety and efficacy of Adebrelimab and SHR-8068 in combination with chemoradiotherapy in subjects with rectal cancer

Study Start Date: March, 2026

Study Type: INTERVENTIONAL

Condition: Locally Advanced Resectable Rectal Cancer

Intervention: DRUG: Adebrelimab in combination with SHR-8068 and chemotherapy

Adebrelimab in combination with SHR-8068 ...